Sinon Corporation (1712.TW)
TWD 43.1
(-0.58%)
TWD 43.1
(-0.58%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.07 Billion TWD | -30.54% |
| 2022 | 2.99 Billion TWD | 51.34% |
| 2021 | 1.97 Billion TWD | 19.75% |
| 2020 | 1.77 Billion TWD | -7.0% |
| 2019 | 1.77 Billion TWD | 8.45% |
| 2018 | 1.61 Billion TWD | 8.64% |
| 2017 | 1.54 Billion TWD | 7.02% |
| 2016 | 1.32 Billion TWD | 16.31% |
| 2015 | 1.36 Billion TWD | -12.04% |
| 2014 | 1.36 Billion TWD | 17.82% |
| 2013 | 1.22 Billion TWD | 18.84% |
| 2012 | 1.1 Billion TWD | 2.36% |
| 2011 | 1 Billion TWD | 23.15% |
| 2010 | 897.36 Million TWD | -15.77% |
| 2009 | 924.23 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 546.7 Million TWD | 26.15% |
| 2024 Q2 | 483.98 Million TWD | -11.47% |
| 2023 Q4 | 433.38 Million TWD | -14.25% |
| 2023 Q2 | 556.9 Million TWD | -4.35% |
| 2023 Q3 | 505.39 Million TWD | -9.25% |
| 2023 FY | - TWD | -30.54% |
| 2023 Q1 | 582.21 Million TWD | 22.55% |
| 2022 Q2 | 675.62 Million TWD | -31.85% |
| 2022 FY | - TWD | 51.34% |
| 2022 Q1 | 991.32 Million TWD | 145.54% |
| 2022 Q3 | 849.59 Million TWD | 25.75% |
| 2022 Q4 | 475.07 Million TWD | -44.08% |
| 2021 Q3 | 495.22 Million TWD | -13.44% |
| 2021 Q2 | 572.08 Million TWD | 12.56% |
| 2021 FY | - TWD | 19.75% |
| 2021 Q1 | 508.25 Million TWD | 32.27% |
| 2021 Q4 | 403.73 Million TWD | -18.48% |
| 2020 Q1 | 289.33 Million TWD | -34.18% |
| 2020 Q4 | 384.26 Million TWD | -16.94% |
| 2020 Q3 | 462.65 Million TWD | -7.91% |
| 2020 FY | - TWD | -7.0% |
| 2020 Q2 | 502.41 Million TWD | 73.65% |
| 2019 Q1 | 480.56 Million TWD | 33.45% |
| 2019 Q3 | 386.73 Million TWD | -17.37% |
| 2019 Q4 | 439.56 Million TWD | 13.66% |
| 2019 FY | - TWD | 8.45% |
| 2019 Q2 | 468.05 Million TWD | -2.6% |
| 2018 Q2 | 575.58 Million TWD | 60.56% |
| 2018 Q4 | 360.11 Million TWD | 5.15% |
| 2018 FY | - TWD | 8.64% |
| 2018 Q1 | 358.47 Million TWD | 5.97% |
| 2018 Q3 | 342.46 Million TWD | -40.5% |
| 2017 Q1 | 333.79 Million TWD | 4.13% |
| 2017 FY | - TWD | 7.02% |
| 2017 Q2 | 427.66 Million TWD | 28.12% |
| 2017 Q4 | 338.29 Million TWD | -16.83% |
| 2017 Q3 | 406.77 Million TWD | -4.89% |
| 2016 FY | - TWD | 16.31% |
| 2016 Q1 | 369.77 Million TWD | -8.53% |
| 2016 Q4 | 320.55 Million TWD | 0.48% |
| 2016 Q3 | 319 Million TWD | -19.93% |
| 2016 Q2 | 398.39 Million TWD | 7.74% |
| 2015 Q4 | 404.24 Million TWD | 47.6% |
| 2015 FY | - TWD | -12.04% |
| 2015 Q2 | 410.38 Million TWD | 236.75% |
| 2015 Q1 | 121.86 Million TWD | -69.95% |
| 2015 Q3 | 273.87 Million TWD | -33.27% |
| 2014 Q2 | 307.19 Million TWD | -19.98% |
| 2014 Q1 | 383.91 Million TWD | 24.18% |
| 2014 FY | - TWD | 17.82% |
| 2014 Q4 | 405.56 Million TWD | 45.19% |
| 2014 Q3 | 279.32 Million TWD | -9.07% |
| 2013 Q1 | 340.65 Million TWD | 73.72% |
| 2013 FY | - TWD | 18.84% |
| 2013 Q4 | 309.15 Million TWD | 4.14% |
| 2013 Q3 | 296.85 Million TWD | 34.2% |
| 2013 Q2 | 221.2 Million TWD | -35.06% |
| 2012 Q3 | 309.92 Million TWD | 35.62% |
| 2012 Q4 | 196.09 Million TWD | -36.73% |
| 2012 FY | - TWD | 2.36% |
| 2012 Q1 | 254.98 Million TWD | -1.06% |
| 2012 Q2 | 228.51 Million TWD | -10.38% |
| 2011 Q1 | 261.84 Million TWD | 28.01% |
| 2011 Q4 | 257.72 Million TWD | 4.65% |
| 2011 Q3 | 246.26 Million TWD | 26.81% |
| 2011 Q2 | 194.19 Million TWD | -25.84% |
| 2011 FY | - TWD | 23.15% |
| 2010 Q4 | 204.55 Million TWD | -3.1% |
| 2010 Q3 | 211.1 Million TWD | 37.93% |
| 2010 Q1 | 210.83 Million TWD | 0.0% |
| 2010 FY | - TWD | -15.77% |
| 2010 Q2 | 153.04 Million TWD | -27.41% |
| 2009 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Taiwan Fertilizer Co., Ltd. | 3.87 Billion TWD | 46.437% |
| All Cosmos Bio-Tech Holding Corporation | 305.41 Million TWD | -580.352% |
| CH Biotech R&D Co., Ltd. | 761.55 Million TWD | -172.849% |